UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022019
Receipt number R000025375
Scientific Title Analysis of the relation between Sho in the concept of Kampo medicine and Genome
Date of disclosure of the study information 2016/04/21
Last modified on 2020/08/04 13:39:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the relation between Sho in the concept of Kampo medicine and Genome

Acronym

Analysis of Sho and Genome

Scientific Title

Analysis of the relation between Sho in the concept of Kampo medicine and Genome

Scientific Title:Acronym

Analysis of Sho and Genome

Region

Japan


Condition

Condition

Patients who are treated in the department of Kampo medicine, Tohoku University Hospital

Classification by specialty

Medicine in general Surgery in general Obstetrics and Gynecology
Pediatrics Ophthalmology Dermatology
Psychiatry Oto-rhino-laryngology Orthopedics
Urology Anesthesiology Oral surgery
Neurosurgery Plastic surgery Rehabilitation medicine
Dental medicine Adult Child

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To clarify the relation between Sho and Genome

Basic objectives2

Others

Basic objectives -Others

Genome

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comprehensive gene cluster group

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

blood sampling

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

110 years-old >=

Gender

Male and Female

Key inclusion criteria

The patients who are treated in the department of Kampo medicine, Tohoku University Hospital

Key exclusion criteria

The patients who do not agree with the study

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Takayama

Organization

Tohoku University Hospital

Division name

Department of Kampo medicine

Zip code

980-8574

Address

1-1, seiryomachi, aobaku, sendai city, miyagi prefecture, Japan

TEL

022-717-7567

Email

takayama@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Akiko
Middle name
Last name Kuwabara

Organization

Tohoku University Hospital

Division name

Department of Kampo medicine

Zip code

980-8574

Address

1-1, seiryomachi, aobaku, sendai city, miyagi prefecture, Japan

TEL

022-717-7507

Homepage URL


Email

takayama@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

Tohoku University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1, seiryomachi, aobaku, sendai city, miyagi prefecture, Japan

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 03 Month 30 Day

Date of IRB


Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 21 Day

Last modified on

2020 Year 08 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025375


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name